Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium for Dyspnea in Advanced NSCLC
NCT01172925Phase 2Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Nov 2010
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tiotropium in Dyspnea, sponsored by Hamilton Health Sciences. Primary endpoint: Cancer Dyspnea Scale at 6 weeks. Status: unknown.
02
Drugs
tiotropium
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT01172925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172925.